Search research articles
Contact Us
Filters
Showing results (21-30 of 27) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 27 results.
Biopharmaceutics & Drug Disposition
|
May 1, 1987
Pharmacokinetics of flurbiprofen in man. I. Area/dose relationships
G J Szpunar, K S Albert, G G Bole, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
March 15, 2000
Characterization of the highly variable bioavailability of tiludronate in normal volunteers using population pharmacokinetic methodologies
G A Maier, G F Lockwood, J A Oppermann, et al.
Clinical Pharmacology and Therapeutics
|
July 1, 1983
Pharmacokinetics of ibuprofen in man. I. Free and total area/dose relationships
G F Lockwood, K S Albert, W R Gillespie, et al.
The Journal of Pharmacy and Pharmacology
|
August 1, 1995
Dose regimen adjustment for milrinone in congestive heart failure patients with moderate and severe renal failure
S G Woolfrey, J Hegbrant, H Thysell, et al.
Biopharmaceutics & Drug Disposition
|
April 1, 1984
Comparative bioavailability study of two tablet formulations of cimetidine
R R Berardi, I A Cohen, M L Hyneck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2000
Phase I pharmacokinetic study of the novel antitumor agent SR233377
P M LoRusso, B J Foster, A Wozniak, et al.
Pharmacogenetics
|
December 12, 2001
In-vivo phenotyping for CYP3A by a single-point determination of midazolam plasma concentration
Y S Lin, G F Lockwood, M A Graham, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 27) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 27 results.
Biopharmaceutics & Drug Disposition
|
May 1, 1987
Pharmacokinetics of flurbiprofen in man. I. Area/dose relationships
G J Szpunar, K S Albert, G G Bole, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
March 15, 2000
Characterization of the highly variable bioavailability of tiludronate in normal volunteers using population pharmacokinetic methodologies
G A Maier, G F Lockwood, J A Oppermann, et al.
Clinical Pharmacology and Therapeutics
|
July 1, 1983
Pharmacokinetics of ibuprofen in man. I. Free and total area/dose relationships
G F Lockwood, K S Albert, W R Gillespie, et al.
The Journal of Pharmacy and Pharmacology
|
August 1, 1995
Dose regimen adjustment for milrinone in congestive heart failure patients with moderate and severe renal failure
S G Woolfrey, J Hegbrant, H Thysell, et al.
Biopharmaceutics & Drug Disposition
|
April 1, 1984
Comparative bioavailability study of two tablet formulations of cimetidine
R R Berardi, I A Cohen, M L Hyneck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2000
Phase I pharmacokinetic study of the novel antitumor agent SR233377
P M LoRusso, B J Foster, A Wozniak, et al.
Pharmacogenetics
|
December 12, 2001
In-vivo phenotyping for CYP3A by a single-point determination of midazolam plasma concentration
Y S Lin, G F Lockwood, M A Graham, et al.
Page
of 3